SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Geron Corp.
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
3576 157 0 GERN
Emcee:  XenaLives Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3376FYI... lef.org lef.org tasciences.com 4-traders.comSavant-9/20/2013
3375This I didn't know. GERN chart looks great,very sweet short term gains. WhatBenny-Rubin-9/20/2013
3374Well, GERN did/does have that co in the Orient that is/was involved in that endeSavant-9/19/2013
3373You have gotta check this out. businessinsider.comBenny-Rubin-9/19/2013
3372Report... Conference Call At 4:30 p.m. EDT on August 8, 2013, Geron's manaSavant-8/9/2013
3371This article suggests it was Imetelstat news more than the finances. finance.yatktrimbath-8/9/2013
3370Appears they liked the report, or, at the least...it wasn't as bad as the shSavant-8/9/2013
3369and this gets a 16% gain on volume? Not that I'm complaining, but any thougdeeno-8/9/2013
3368 Geron reports EPS in-line, misses on revsReports Q2 (Jun) GAAP Savant-8/8/2013
3367BTX 18% shares shorted, fwiw....The Ox-8/6/2013
3366BioTime's Subsidiary OncoCyte Corporation Publishes Data on the Gene FSIP1 aSavant-8/6/2013
3365BioTime Subsidiary LifeMap Sciences Announces Publication of Research Report DesSavant-8/6/2013
3364BioTime CEO Dr. Michael West to Present at the Case Western Reserve University 6Savant-8/6/2013
3363INTRO Here's my semi-annual exercise to see if I remember why I own the stoctktrimbath16/30/2013
3362I do find you in the weirdest places. So that report mean anything to you?deeno-6/21/2013
3361Geron reports updated results from its Imetelstat Phase 2 proof-of-concept trialSavant16/17/2013
3360Geron Unveils Further Work Cuts, Discontinues Discovery Research Program BySavant-4/25/2013
3359RT.. BioTime Appoints Stephen C. Farrell to Board of Directors ALAMEDA, CalifSavant-3/12/2013
3358RT...BioTime's Subsidiary OncoCyte Corporation Provides an Update on the DevSavant-2/1/2013
3357RT... LifeMap Sciences, a Subsidiary of BioTime, Announces Publication of ResearSavant-2/1/2013
3356BioTime Signs Definitive Agreement With Geron Regarding Stem Cell Assets InvesSavant-1/7/2013
3355I had pretty much left GERN for dead. But their data with imetelstat against essmcbio-1/1/2013
3354My End of Year Review of GERN INTRO Here's my semi-annual exercise to see itktrimbath-12/31/2012
3353Geron presents positive results from Phase 2 study of imetelstat in essential thSavant-12/10/2012
3352Geron Discontinues GRN1005 and Restructures to Focus on Imetelstat Development iSavant-12/3/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News